CARL Share Price Performance
US$10.94
-3.56 (-24.55%)
54.4% undervalued intrinsic discount
US$24.00
Fair Value
Price US$10.94
AnalystHighTarget US$24.00
AnalystConsensusTarget US$19.40
AnalystLowTarget US$17.00
Fair ValueUS$24.00
Share Pricen/a
Carlsmed, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
CARL Community Narratives
AN
Fair Value US$24 54.4% undervalued intrinsic discount
AI Spine Surgery And Personalized Implants Will Transform Long-Term Earnings Potential
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$19.4 43.6% undervalued intrinsic discount
Personalized Spine Surgery Will Reshape A US$13b Market Over The Long Term
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value US$17 35.6% undervalued intrinsic discount
Surgeon Concentration And Reimbursement Risks Will Persist Yet Eventually Support A Stronger Business
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Personalized Spine Surgery Will Reshape A US$13b Market Over The Long Term
Catalysts About Carlsmed Carlsmed provides a digital surgery platform and patient specific 3D printed spine implants for lumbar and cervical fusion procedures. What are the underlying business or industry changes driving this perspective?Read more
8
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$19.4
43.6% undervalued intrinsic discount
Fair Value
Profit Margin
13.57%
Future PE
44.42x
Price in 2029
US$24.28
AI Spine Surgery And Personalized Implants Will Transform Long-Term Earnings Potential
Catalysts About Carlsmed Carlsmed provides a digital surgery platform and patient specific spine implants designed to improve alignment and reduce revision procedures. What are the underlying business or industry changes driving this perspective?Read more
7
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$24
54.4% undervalued intrinsic discount
Fair Value
Profit Margin
12.92%
Future PE
52.06x
Price in 2029
US$30.03
Surgeon Concentration And Reimbursement Risks Will Persist Yet Eventually Support A Stronger Business
Catalysts About Carlsmed Carlsmed provides an AI driven digital surgery platform with patient specific 3D printed spine implants and single use instrument kits. What are the underlying business or industry changes driving this perspective?Read more
6
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$17
35.6% undervalued intrinsic discount
Fair Value
Profit Margin
12.9%
Future PE
39.28x
Price in 2029
US$21.3
Trending Discussion
Recently Updated Narratives
AN
Personalized Spine Surgery Will Reshape A US$13b Market Over The Long Term
Fair Value: US$19.4 43.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI Spine Surgery And Personalized Implants Will Transform Long-Term Earnings Potential
Fair Value: US$24 54.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Surgeon Concentration And Reimbursement Risks Will Persist Yet Eventually Support A Stronger Business
Fair Value: US$17 35.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Carlsmed, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 05, 2026
- -1.13
- 75.31%
- -59.82%
- 15.5%
About CARL
- Founded
- 2018
- Employees
- 127
- CEO
- WebsiteView website
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
